Mineralys Therapeutics Statistics
Total Valuation
MLYS has a market cap or net worth of $595.57 million. The enterprise value is $359.01 million.
| Market Cap | 595.57M |
| Enterprise Value | 359.01M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MLYS has 49.63 million shares outstanding. The number of shares has increased by 600.33% in one year.
| Shares Outstanding | 49.63M |
| Shares Change (YoY) | +600.33% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 92.49% |
| Float | 22.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.77, with zero debt.
| Current Ratio | 23.77 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.50% and return on invested capital (ROIC) is -35.10%.
| Return on Equity (ROE) | -26.50% |
| Return on Assets (ROA) | -25.50% |
| Return on Capital (ROIC) | -35.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.57M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.44% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -11.44% |
| 50-Day Moving Average | 13.71 |
| 200-Day Moving Average | 11.18 |
| Relative Strength Index (RSI) | 37.19 |
| Average Volume (30 Days) | 169,843 |
Short Selling Information
The latest short interest is 850,456, so 1.71% of the outstanding shares have been sold short.
| Short Interest | 850,456 |
| Short Previous Month | 842,101 |
| Short % of Shares Out | 1.71% |
| Short % of Float | 3.70% |
| Short Ratio (days to cover) | 5.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -84.66M |
| Pretax Income | -71.90M |
| Net Income | -71.90M |
| EBITDA | -71.90M |
| EBIT | -71.90M |
| Earnings Per Share (EPS) | -$1.99 |
Balance Sheet
The company has $236.57 million in cash and no debt, giving a net cash position of $236.57 million or $4.77 per share.
| Cash & Cash Equivalents | 236.57M |
| Total Debt | n/a |
| Net Cash | 236.57M |
| Net Cash Per Share | $4.77 |
| Equity / Book Value | 241.15M |
| Book Value Per Share | 4.86 |
| Working Capital | 238.62M |
Cash Flow
| Operating Cash Flow | -81.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | -81.17M |
| FCF Per Share | -$2.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MLYS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -600.33% |
| Shareholder Yield | -600.33% |
| Earnings Yield | -12.07% |
| FCF Yield | -13.63% |
Analyst Forecast
The average price target for MLYS is $30.00, which is 150.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.00 |
| Price Target Difference | 150.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 4.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |